Linda A Teagle
Obstetrics/Gynecology · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 28
- 6 carriers
- Office
- 1
Offices
1 location · UCSF Health Medical Foundation · 40 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
28 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Linda A Teagle’s office at (650) 701-1882 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
28 of 28 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G66866 · Current
Licensed to practise in California · since 1989 · expires 2029-01-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$19,940
Medicare paid this office $19,940 for 134 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 40 | $4,412 | $110 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 90 | $4,255 | $47 |
| Short return visit (20+ min) | 37 | $3,334 | $76 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 56 | $3,209 | $57 |
| Short return visit | 21 | $912 | $34 |
See all 9 services
| Return visit (30+ min) | 40 | $4,412 | $110 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 90 | $4,255 | $47 |
| Short return visit (20+ min) | 37 | $3,334 | $76 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 56 | $3,209 | $57 |
| Short return visit | 21 | $912 | $34 |
| Detection test for candida species (yeast), direct probe technique | 17 | $378 | $19 |
| Detection test for gardnerella vaginalis (bacteria), direct probe technique | 16 | $363 | $19 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique | 15 | $344 | $19 |
| Blood count, hemoglobin | 98 | $230 | $2 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
134 Original Medicare patients in 2024. Average age 73 · Women 100% · Health risk score 0.72. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 60% · Diabetes 16% · Cancer 14% · Coronary heart disease 13% · Atrial fibrillation 11% · Depression 10%.
The office billed $87,074, Medicare allowed $24,914 and paid $19,940; for 436 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 134 | 436 | 73 | 0.72 | $87,074 | $19,940 |
| 2023 | 132 | 388 | 73 | 0.68 | $81,475 | $15,599 |
| 2022 | 129 | 333 | 73 | 0.64 | $54,647 | $14,782 |
| 2021 | 123 | 447 | 72 | 0.67 | $64,848 | $19,788 |
| 2020 | 110 | 437 | 73 | 0.63 | $60,721 | $17,104 |
| 2019 | 136 | 474 | 73 | 0.76 | $32,814 | $16,867 |
| 2018 | 146 | 433 | 73 | 0.78 | $34,237 | $15,917 |
| 2017 | 123 | 403 | 72 | 0.81 | $41,293 | $15,773 |
| 2016 | 179 | 635 | 72 | 0.88 | $40,621 | $28,638 |
| 2015 | 176 | 551 | 72 | 0.84 | $38,813 | $29,713 |
| 2014 | 157 | 451 | 72 | 0.83 | $30,759 | $23,513 |
| 2013 | 155 | 334 | 72 | 0.75 | $26,775 | $20,163 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 73 | $3,712 | $51 |
| Short return visit (20+ min) | 31 | $3,134 | $75 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 60 | $2,609 | $43 |
| Return visit (30+ min) | 12 | $1,145 | $88 |
| Short return visit | 16 | $798 | $42 |
| Detection test for candida species (yeast), direct probe technique | 13 | $295 | $20 |
| Detection test for gardnerella vaginalis (bacteria), direct probe technique | 13 | $295 | $20 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique | 13 | $295 | $20 |
| Blood count, hemoglobin | 102 | $241 | $2 |
2022: 5 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 100 | $4,784 | $48 |
| Short return visit (20+ min) | 25 | $2,967 | $85 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 38 | $2,091 | $55 |
| Complete ultrasound scan of pelvis | 12 | $1,474 | $113 |
| Blood count, hemoglobin | 98 | $229 | $2 |
2021: 8 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $7,899 | $161 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 62 | $3,457 | $56 |
| Short return visit (20+ min) | 26 | $2,603 | $77 |
| Return visit (30+ min) | 12 | $1,260 | $105 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 24 | $1,164 | $48 |
| Insertion of needle into vein for collection of blood sample | 81 | $246 | $3 |
| Urinalysis, manual test | 64 | $226 | $3 |
| Blood count, hemoglobin | 95 | $225 | $2 |
2020: 7 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $4,126 | $142 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 59 | $3,229 | $55 |
| Short return visit (20+ min) | 17 | $2,577 | $66 |
| Return visit (30+ min) | 20 | $2,125 | $97 |
| Urinalysis, manual test | 77 | $274 | $3 |
| Insertion of needle into vein for collection of blood sample | 81 | $254 | $3 |
| Blood count, hemoglobin | 80 | $189 | $2 |
2019: 8 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 62 | $3,342 | $54 |
| Short return visit (20+ min) | 28 | $2,995 | $70 |
| Long return visit (40+ min) | 18 | $2,459 | $137 |
| Return visit (30+ min) | 18 | $2,158 | $98 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $651 | $47 |
| Insertion of needle into vein for collection of blood sample | 98 | $288 | $3 |
| Blood count, hemoglobin | 100 | $258 | $3 |
| Urinalysis, manual test | 65 | $232 | $3 |
2018: 6 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 80 | $4,163 | $52 |
| Short return visit (20+ min) | 28 | $2,407 | $60 |
| Return visit (30+ min) | 21 | $2,303 | $89 |
| Insertion of needle into vein for collection of blood sample | 103 | $309 | $3 |
| Blood count, hemoglobin | 104 | $301 | $3 |
| Urinalysis, manual test | 23 | $78 | $3 |
2017: 8 services
| Short return visit (20+ min) | 39 | $3,440 | $57 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 61 | $3,147 | $52 |
| Return visit (30+ min) | 14 | $1,576 | $93 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 13 | $556 | $43 |
| Blood count, hemoglobin | 76 | $248 | $3 |
| Insertion of needle into vein for collection of blood sample | 76 | $229 | $3 |
| Wet mounts, including preparations of vaginal, cervical or skin specimens | 16 | $92 | $6 |
| Urinalysis, manual test | 24 | $89 | $3 |
2016: 8 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 82 | $11,062 | $135 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 95 | $4,219 | $44 |
| Short return visit (20+ min) | 46 | $4,130 | $57 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 13 | $1,816 | $121 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 31 | $1,682 | $54 |
| Insertion of needle into vein for collection of blood sample | 126 | $370 | $3 |
| Blood count, hemoglobin | 109 | $346 | $3 |
| Urinalysis, manual test | 40 | $147 | $3 |
2015: 6 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 98 | $13,368 | $136 |
| Short return visit (20+ min) | 48 | $4,621 | $62 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 51 | $2,798 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 43 | $1,930 | $45 |
| Insertion of needle into vein for collection of blood sample | 116 | $344 | $3 |
| Blood count, hemoglobin | 102 | $323 | $3 |
2014: 7 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 35 | $4,661 | $133 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 99 | $4,431 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 86 | $4,254 | $49 |
| Short return visit (20+ min) | 32 | $3,085 | $64 |
| Blood count, hemoglobin | 42 | $133 | $3 |
| Insertion of needle into vein for collection of blood sample | 41 | $121 | $3 |
| Stool analysis for blood to screen for colon tumors | 11 | $48 | $4 |
2013: 6 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 38 | $5,064 | $133 |
| Short return visit (20+ min) | 36 | $3,123 | $60 |
| Return visit (30+ min) | 29 | $2,905 | $94 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 61 | $2,775 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 60 | $1,435 | $24 |
| Short return visit | 12 | $466 | $39 |
Drugs they prescribed that Part D paid
$11,221
Pharmacies billed $11,221 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 150) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
136 generic and 14 brand-name prescriptions · $11,221 in drug cost · 25 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 25 | $1,831 | $73 |
| Valacyclovir | 12 | $606 | $51 |
| Clobetasol Propionate | 12 | $383 | $32 |
| Nitrofurantoin Mono-Macro | 22 | $316 | $14 |
| Acyclovir | 12 | $290 | $24 |
See all 7 drugs
| Estradiol | 25 | $1,831 | $73 |
| Valacyclovir | 12 | $606 | $51 |
| Clobetasol Propionate | 12 | $383 | $32 |
| Nitrofurantoin Mono-Macro | 22 | $316 | $14 |
| Acyclovir | 12 | $290 | $24 |
| Progesterone | 15 | $275 | $18 |
| Clotrimazole-Betamethasone | 14 | $262 | $19 |
Year by year
| 2024 | 150 | 53 | 0% (0) | 9% | $11,221 |
| 2023 | 175 | 53 | 0% (0) | 20% | $15,248 |
| 2022 | 153 | 44 | 0% (0) | 34% | $14,555 |
| 2021 | 130 | 45 | 0% (0) | 31% | $15,826 |
| 2020 | 170 | 51 | None | 23% | $19,885 |
| 2019 | 164 | 51 | 0% (0) | 23% | $16,967 |
| 2018 | 152 | 59 | 0% (0) | 24% | $14,025 |
| 2017 | 170 | 48 | 0% (0) | 25% | $17,997 |
| 2016 | 199 | 52 | None | 39% | $19,647 |
| 2015 | 150 | 55 | 0% (0) | 49% | $19,314 |
| 2014 | 135 | 54 | 0% (0) | 50% | $15,205 |
| 2013 | 134 | 42 | 0% (0) | 66% | $15,914 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Estradiol | 26 | $1,805 | $69 |
| Estradiol (Twice Weekly) | 14 | $1,510 | $108 |
| Valacyclovir | 13 | $762 | $59 |
| Progesterone | 22 | $655 | $30 |
| Clotrimazole-Betamethasone | 19 | $640 | $34 |
| Nitrofurantoin Mono-Macro | 16 | $620 | $39 |
2022: 5 drugs
| Clobetasol Propionate | 13 | $1,323 | $102 |
| Estradiol (Twice Weekly) | 19 | $1,255 | $66 |
| Estradiol | 16 | $796 | $50 |
| Nitrofurantoin Mono-Macro | 21 | $525 | $25 |
| Progesterone | 16 | $516 | $32 |
2021: 3 drugs
| Estradiol | 20 | $1,973 | $99 |
| Estradiol (Twice Weekly) | 13 | $881 | $68 |
| Progesterone | 18 | $638 | $35 |
2020: 4 drugs
| Estradiol | 26 | $3,294 | $127 |
| Estradiol (Twice Weekly) | 24 | $3,020 | $126 |
| Progesterone | 19 | $829 | $44 |
| Clotrimazole-Betamethasone | 18 | $318 | $18 |
2019: 4 drugs
| Estradiol | 45 | $5,728 | $127 |
| Progesterone | 18 | $942 | $52 |
| Clotrimazole-Betamethasone | 18 | $392 | $22 |
| Alendronate | 11 | $130 | $12 |
2018: 3 drugs
| Estradiol | 30 | $2,891 | $96 |
| Clotrimazole-Betamethasone | 19 | $376 | $20 |
| Alendronate | 12 | $58 | $5 |
2017: 3 drugs
| Estradiol | 37 | $2,465 | $67 |
| Progesterone | 17 | $1,339 | $79 |
| Clotrimazole-Betamethasone | 17 | $333 | $20 |
2016: 5 drugs
| Estradiol | 50 | $2,303 | $46 |
| Evamist | 13 | $1,452 | $112 |
| Progesterone | 19 | $940 | $49 |
| Clotrimazole-Betamethasone | 15 | $248 | $17 |
| Nitrofurantoin Mono-Macro | 11 | $201 | $18 |
2015: 4 drugs
| Estradiol | 21 | $2,653 | $126 |
| Progesterone | 25 | $2,076 | $83 |
| Evamist | 11 | $1,096 | $100 |
| Nitrofurantoin Mono-Macro | 12 | $221 | $18 |
2014: 2 drugs
| Progesterone | 20 | $1,136 | $57 |
| Clotrimazole-Betamethasone | 16 | $350 | $22 |
2013: 3 drugs
| Vivelle-Dot | 21 | $3,032 | $144 |
| Progesterone | 14 | $963 | $69 |
| Clotrimazole-Betamethasone | 18 | $501 | $28 |
Money from drug and device companies
$557 in 2025
| 2025 | 3 | 10 | $150 | $557 |
| 2024 | 2 | 15 | None | $290 |
| 2023 | 4 | 15 | None | $615 |
| 2022 | 1 | 1 | None | $140 |
| 2021 | 1 | 1 | None | $7 |
| 2020 | 1 | 1 | None | $18 |
| 2019 | 12 | 20 | None | $760 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Veozah | $391 | 8 payments
|
| Pfizer | Nurtec Odt | $150 | 1 payment
|
| Hologic Sales and Service | Myosure Tissue Removal Device | $16 | 1 payment
|
See all 10 published payments
| Astellas Pharma US | Meals · 2025-10-29 | Veozah | $125 |
| Astellas Pharma US | Meals · 2025-10-28 | Veozah | $16 |
| Astellas Pharma US | Meals · 2025-09-17 | Veozah | $33 |
| Pfizer | Consulting · 2025-09-03 | Nurtec Odt | $150 |
| Astellas Pharma US | Meals · 2025-08-27 | Veozah | $24 |
| Astellas Pharma US | Meals · 2025-07-17 | Veozah | $27 |
| Hologic Sales and Service | Meals · 2025-05-15 | Myosure Tissue Removal Device | $16 |
| Astellas Pharma US | Meals · 2025-04-18 | Veozah | $20 |
| Astellas Pharma US | Meals · 2025-03-04 | Veozah | $21 |
| Astellas Pharma US | Meals · 2025-01-30 | Veozah | $125 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $290
| Astellas Pharma US | Veozah | $179 | 3 payments
|
| Mayne Pharma Commercial | None | $111 | 12 payments
|
2023: $615
| Mayne Pharma Commercial | Nextstellis | $338 | 11 payments
|
| Minerva Surgical | None | $203 | 1 payment
|
| Astellas Pharma US | Veozah | $53 | 2 payments
|
| Sumitomo Pharma America | Myfembree | $21 | 1 payment
|
2022: $140
| Hologic | Acessa Provu System | $140 | 1 payment
|
2021: $7
| Organon | None | $7 | 1 payment
|
2020: $18
| Avion Pharmaceuticals | Balcoltra | $18 | 1 payment
|
2019: $760
| Medtronic USA | Kyphon Balloon Kyphoplasty | $167 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $125 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $125 | 1 payment
|
| Terumo Medical | Glidesheath | $104 | 1 payment
|
| Vertical Pharmaceuticals | Divigel | $64 | 4 payments
|
| AbbVie | Orilissa | $42 | 2 payments
|
| AMAG Pharmaceuticals | Intrarosa | $32 | 2 payments
|
| TherapeuticsMD | Imvexxy | $29 | 2 payments
|
| ASCEND Therapeutics US | Estrogel | $22 | 2 payments
|
| Merck Sharp & Dohme | Nexplanon | $20 | 1 payment
|
| Allergan | Lo Loestrin Fe | $17 | 1 payment
|
| Roche Diagnostics | Rs Harmony Test Related Products | $13 | 1 payment
|
Professional record
- NPI
- 1972590495
- Licence
- CA G66866California G66866: Current · expires 2029-01-31
- Trained
- University of California, Irvine, California College of Medicine, 1989
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G668660
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 777 Knowles Dr, Suite 7, Los Gatos, CA, 95032
- NPI first listed
- 2005-09-30
- NPI last updated
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.